To further determine how RAB32 influenced the proliferation, migration, and apoptosis of CML cells, we used human RAB32-specific siRNA to knockdown RAB32 expression in K562 cells (Figures 6A, B). This evidence concerns the gene RAB32 and chronic myelogenous leukemia, BCR-ABL1 positive.